Thomas Varghese Jr., MD, MS, MBA, FACS, discusses the IMPACT Center’s role advancing cancer care through innovation, AI, mobile clinics, and telehealth, ensuring high-quality treatment reaches patients in underserved communities.
Huntsman Cancer Institute’s 2024 highlights of discovery and innovation include a new drug pairing for brain cancer, a groundbreaking study into health care barriers, and more.
Huntsman Cancer Institute is breaking ground on a new location in Vineyard in April 2025, expanding access to cancer care and research and bringing lifesaving resources closer to home.
The HCI-UVU Health Collaborative offers interns hands-on research, cancer center professional services, and clinical volunteer services to prepare students for impactful careers in cancer research and health care.
Surgeon General Vivek Murthy released an advisory to increase public awareness that alcohol use can increase the risk of cancer, as only 45% of Americans are aware of the connection.
Gita Suneja, MD, MSHP, shares her personal cancer story, her passion for fostering future researchers and investigators, and the importance of being an advocate for cancer patients.
The introduction of two da Vinci 5 systems enhances surgery precision and decreases recovery times for patients. This strengthens Huntsman Cancer Institute’s role as a leader in robotic surgical care.
As director of Huntsman Cancer Institute’s biorepository, Filmore and his team advance cancer care by collecting patient samples, unraveling molecular mysteries, and assisting in the creation of innovative treatments.
Huntsman Cancer Institute joins with other institutions through myeloMATCH, a program that matches patients with clinical trials that specifically target their disease.
Huntsman Cancer Institute researchers have identified a gene variant found in a high-altitude Andean population that may predict severity of diseases and responses to treatments for patients with certain types...
Chelsey Schlechter, MPH, PhD, has been chosen as a Cancer Moonshot Scholar. She is one of eleven researchers from across the country who have been selected for the prestigious honor.
The National Cancer Institute recognized Huntsman Cancer Institute investigator Minna Roh-Johnson for excellence in diversity, equity, inclusion, and accessibility. Roh-Johnson explains the importance of mentorship and diversity in scientific research.
A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
Hormone replacement therapy helps women counteract the side effects of menopause. But could it also increase the odds of getting cancer? Cindy Matsen, MD, talks through the risks and benefits.
The Princess of Wales shocked the world when she announced she was undergoing “preventative chemotherapy” for cancer. We asked oncologist Heloisa Soares to help us understand this type of treatment.
